Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular transport of ascorbic acid (vitamin C) is primarily mediated by sodium-dependent vitamin C transporters, SVCT1 and SVCT2, encoded by the SLC23A1 and SLC23A2 genes. SVCT1 is mainly expressed in epithelial tissues (kidney, intestine) and is responsible for maintaining whole-body vitamin C levels. SVCT2 is expressed more broadly (including the brain) and is crucial for distributing vitamin C to individual tissues. Both function as sodium-ascorbate symporters with a 2:1 sodium-to-ascorbate stoichiometry, enabling active uptake of ascorbic acid against a concentration gradient. For the oxidized form (dehydroascorbic acid), cellular entry occurs via facilitated diffusion through glucose transporters (GLUT1, GLUT3, GLUT4), important in some tissues. These transporters are essential for antioxidant protection, redox balance, and diverse roles in metabolism and disease, including cancer, neurological disorders, and scurvy[1][2][3][4].
Active, sodium-coupled co-transport of ascorbic acid (reduced form) via SVCT transporters Facilitated diffusion of dehydroascorbic acid (oxidized form) via GLUTs, followed by intracellular reduction
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ascorbic acid cellular transport.